EUCTR2008-000569-50-IT进行中（未招募）1 期
Allogeneic stem cell transplantation for children and adolescents with CML: Conditioning regimen, donor selection, supportive care and diagnostic procedures - CML SCT I-BFM
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Children and adolescents (age between 1 and 18 years) with bcr-abl positive CML in chronic phase, who are eligible for allogeneic stem cell transplantation, irrespective of the previous treatment strategy Availability of a matched sibling donor (MSD), a matched family donor, a matched unrelated donor or a matched unrelated cord blood (MD) Informed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Unavailability of MSD or MD Patients in accelerated phase or blast crisis Pregnancy Previous autologous or allogeneic SCT No informed consent
研究者
相似试验
进行中（未招募）
1 期
Allogeneic stem cell transplantation for children, adolescents and young adults with acute myeloid leukemiaEUCTR2007-004517-34-CZHannover Clinical Trial Center GmbH153
进行中（未招募）
1 期
Stem cell transplantation for young people with severe blood cancerRelapsed or refractory Acute Myeloid Leukemia (AML)MedDRA version: 20.0 Level: LLT Classification code 10000886 Term: Acute myeloid leukemia System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10067859 Term: Allogenic stem cell transplantation System Organ Class: 100000004865EUCTR2007-004517-34-DEHannover Medical School153
进行中（未招募）
1 期
Allogeneic stem cell transplantation for children, adolescents and young adults with relapsed or refractory AML - AML SCT-BFM 2007To evaluate whether stem cell transplantation from a matched sibling donor is equivalent to a matched unrelated donor in a second complete remissionto evaluate whether stem cell transplantation after FLAMSA increases survival compared to a threshold derived from historical data (1-year Survival 10%)to evaluate whether stem cell transplantation from haploidentical donors for children having no matched donor will result in better survival with acceptable toxicity.EUCTR2007-004517-34-ATHannover Clinical Trial Center GmbH136
招募中
3 期
ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia2024-512657-24-00St. Anna Childrens Cancer Research Institute GmbH1,108
进行中（未招募）
1 期
Allogenic stem cell transplantation in children and adolescents with acute lymphoblastic leukaemia - ALL SCT BFM internationalvery high risk acute lymphoblastic leukaemia in children and adolescents with indicaton for allogenic hematopoetic stem cell transplantationMedDRA version: 8.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaEUCTR2005-005106-23-ATSt. Anna Kinderkrebsforschung405